-
Repurposing authorised medicines in the EU
Repurposing authorised medicines in the EU
-
Repurposing authorised medicines in the EU
Repurposing authorised medicines in the EU
EMA and Heads of Medicines Agencies are launching a pilot project to support not-for-profit organisations and academia in the repurposing of medicines
-
Info day on EMA support to veterinary SMEs
Info day on EMA support to veterinary SMEs
-
Info day on EMA support to veterinary SMEs
Info day on EMA support to veterinary SMEs
The event takes place on 28 October (10:00-16:00) and explains how SMEs can benefit from early dialogue and interaction with EMA during development of innovative veterinary medicines
-
EMA organises its 4th public meeting on COVID-19
EMA organises its 4th public meeting on COVID-19
-
EMA organises its 4th public meeting on COVID-19
EMA organises its 4th public meeting on COVID-19
The meeting will take place on 25 November 2021 and will update European citizens on the approval and safety monitoring of COVID-19 vaccines and therapeutics in the EU
-
EMA recommendation on Spikevax booster
EMA recommendation on Spikevax booster
-
EMA recommendation on Spikevax booster
EMA recommendation on Spikevax booster
EMA concludes that a booster dose of the COVID-19 vaccine Spikevax may be considered in people aged 18 years and above
